Summary

The saliva based screening market is witnessing steady growth due to increasing demand for non-invasive diagnostic solutions, rising prevalence of infectious and chronic diseases, and growing adoption of advanced molecular diagnostic technologies. Saliva-based screening has emerged as an effective alternative to traditional blood-based testing owing to its convenience, painless sample collection, and rapid diagnostic capabilities. The Saliva Based Screening Market is expected to reach US$ 385.5 Mn in 2026 and US$ 611 Mn by 2033, growing at a CAGR of 6.80% during the forecast period.

Market Insights:

The industry is evolving rapidly with advancements in molecular diagnostics, genomic testing, and biomarker analysis using saliva samples. Healthcare providers and research institutions are increasingly utilizing saliva-based screening methods for disease detection, genetic analysis, and personalized medicine applications. The growing use of saliva diagnostics in infectious disease testing, hormone monitoring, and drug screening is significantly enhancing market growth. Furthermore, technological developments in nucleic acid purification and portable diagnostic devices are improving testing accuracy, reliability, and turnaround time.

Drivers:

Major drivers of the saliva based screening market include increasing preference for non-invasive diagnostic procedures, growing awareness regarding early disease detection, and rising demand for point-of-care testing solutions. The expanding geriatric population and increasing prevalence of chronic and infectious diseases are further boosting the need for efficient screening technologies. Advancements in genomic and proteomic research, along with increasing investment in precision medicine, are also supporting market expansion. In addition, the ease of saliva sample collection and reduced risk of contamination compared to blood sampling are encouraging broader adoption across healthcare settings.

Business Opportunity:

The market presents significant opportunities for companies developing innovative saliva collection devices, rapid detection kits, and advanced molecular testing platforms. Emerging economies offer strong growth potential due to improving healthcare infrastructure and rising investments in diagnostic laboratories and research facilities. Increasing adoption of saliva-based liquid biopsy and pharmacogenomic testing is expected to create new revenue streams for market participants. Strategic partnerships between biotechnology firms, research institutes, and healthcare providers are also accelerating product innovation and commercialization activities.

Region Analysis:

North America dominates the saliva based screening market owing to advanced healthcare infrastructure, strong presence of leading diagnostic companies, and high adoption of innovative screening technologies. Europe holds a considerable market share supported by increasing research activities and growing focus on personalized medicine. The Asia Pacific region is anticipated to witness the fastest growth due to expanding healthcare access, rising healthcare expenditure, and increasing awareness regarding non-invasive diagnostics in countries such as China, India, and Japan. Latin America and the Middle East & Africa are gradually experiencing market growth with ongoing improvements in healthcare infrastructure and diagnostic capabilities.

Key Players:

• Thermo Fisher Scientific, Inc.

• Abbott Laboratories

• OraSure Technologies, Inc.

• Quest Diagnostics Incorporated

• Laboratory Corporation of America (LabCorp)

• Salimetrics, LLC

• Neogen Corporation

• Hologic, Inc.

• F. Hoffmann-La Roche Ltd

• QIAGEN N.V.

Segmentation:

By Product

• Saliva Collection Devices

• Saliva Nucleic Acid Purification Kits

• Saliva Base Detection Kits

By Purpose

• Research

• Diagnostics

By Application

• Infection analysis/detection

• Genomic analysis

• Proteomics

• Pharmacogenomics

• Liquid biopsy

By End User

• Hospitals & Clinics

• Diagnostic laboratories

• Academic & research institutes

• Biopharmaceuticals & CRO’s

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Saliva Based Screening Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Saliva Based Screening Market Outlook, 2020 - 2033
3.1. Global Saliva Based Screening Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
3.1.1. Saliva Collection Devices
3.1.2. Saliva Nucleic Acid Purification Kits
3.1.3. Saliva Base Detection Kits
3.2. Global Saliva Based Screening Market Outlook, by Purpose, Value (US$ Mn), 2020-2033
3.2.1. Research
3.2.2. Diagnostics
3.3. Global Saliva Based Screening Market Outlook, by Application, Value (US$ Mn), 2020-2033
3.3.1. Infection analysis/detection
3.3.2. Genomic analysis
3.3.3. Proteomics
3.3.4. Pharmacogenomics
3.3.5. Liquid biopsy
3.4. Global Saliva Based Screening Market Outlook, by End User, Value (US$ Mn), 2020-2033
3.4.1. Hospitals & Clinics
3.4.2. Diagnostic laboratories
3.4.3. Academic & research institutes
3.4.4. Biopharmaceuticals & CRO’s
3.5. Global Saliva Based Screening Market Outlook, by Region, Value (US$ Mn), 2020-2033
3.5.1. North America
3.5.2. Europe
3.5.3. Asia Pacific
3.5.4. Latin America
3.5.5. Middle East & Africa
4. North America Saliva Based Screening Market Outlook, 2020 - 2033
4.1. North America Saliva Based Screening Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
4.1.1. Saliva Collection Devices
4.1.2. Saliva Nucleic Acid Purification Kits
4.1.3. Saliva Base Detection Kits
4.2. North America Saliva Based Screening Market Outlook, by Purpose, Value (US$ Mn), 2020-2033
4.2.1. Research
4.2.2. Diagnostics
4.3. North America Saliva Based Screening Market Outlook, by Application, Value (US$ Mn), 2020-2033
4.3.1. Infection analysis/detection
4.3.2. Genomic analysis
4.3.3. Proteomics
4.3.4. Pharmacogenomics
4.3.5. Liquid biopsy
4.4. North America Saliva Based Screening Market Outlook, by End User, Value (US$ Mn), 2020-2033
4.4.1. Hospitals & Clinics
4.4.2. Diagnostic laboratories
4.4.3. Academic & research institutes
4.4.4. Biopharmaceuticals & CRO’s
4.5. North America Saliva Based Screening Market Outlook, by Country, Value (US$ Mn), 2020-2033
4.5.1. U.S. Saliva Based Screening Market Outlook, by Product Type, 2020-2033
4.5.2. U.S. Saliva Based Screening Market Outlook, by Purpose, 2020-2033
4.5.3. U.S. Saliva Based Screening Market Outlook, by Application, 2020-2033
4.5.4. U.S. Saliva Based Screening Market Outlook, by End User, 2020-2033
4.5.5. Canada Saliva Based Screening Market Outlook, by Product Type, 2020-2033
4.5.6. Canada Saliva Based Screening Market Outlook, by Purpose, 2020-2033
4.5.7. Canada Saliva Based Screening Market Outlook, by Application, 2020-2033
4.5.8. Canada Saliva Based Screening Market Outlook, by End User, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Saliva Based Screening Market Outlook, 2020 - 2033
5.1. Europe Saliva Based Screening Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
5.1.1. Saliva Collection Devices
5.1.2. Saliva Nucleic Acid Purification Kits
5.1.3. Saliva Base Detection Kits
5.2. Europe Saliva Based Screening Market Outlook, by Purpose, Value (US$ Mn), 2020-2033
5.2.1. Research
5.2.2. Diagnostics
5.3. Europe Saliva Based Screening Market Outlook, by Application, Value (US$ Mn), 2020-2033
5.3.1. Infection analysis/detection
5.3.2. Genomic analysis
5.3.3. Proteomics
5.3.4. Pharmacogenomics
5.3.5. Liquid biopsy
5.4. Europe Saliva Based Screening Market Outlook, by End User, Value (US$ Mn), 2020-2033
5.4.1. Hospitals & Clinics
5.4.2. Diagnostic laboratories
5.4.3. Academic & research institutes
5.4.4. Biopharmaceuticals & CRO’s
5.5. Europe Saliva Based Screening Market Outlook, by Country, Value (US$ Mn), 2020-2033
5.5.1. Germany Saliva Based Screening Market Outlook, by Product Type, 2020-2033
5.5.2. Germany Saliva Based Screening Market Outlook, by Purpose, 2020-2033
5.5.3. Germany Saliva Based Screening Market Outlook, by Application, 2020-2033
5.5.4. Germany Saliva Based Screening Market Outlook, by End User, 2020-2033
5.5.5. Italy Saliva Based Screening Market Outlook, by Product Type, 2020-2033
5.5.6. Italy Saliva Based Screening Market Outlook, by Purpose, 2020-2033
5.5.7. Italy Saliva Based Screening Market Outlook, by Application, 2020-2033
5.5.8. Italy Saliva Based Screening Market Outlook, by End User, 2020-2033
5.5.9. France Saliva Based Screening Market Outlook, by Product Type, 2020-2033
5.5.10. France Saliva Based Screening Market Outlook, by Purpose, 2020-2033
5.5.11. France Saliva Based Screening Market Outlook, by Application, 2020-2033
5.5.12. France Saliva Based Screening Market Outlook, by End User, 2020-2033
5.5.13. U.K. Saliva Based Screening Market Outlook, by Product Type, 2020-2033
5.5.14. U.K. Saliva Based Screening Market Outlook, by Purpose, 2020-2033
5.5.15. U.K. Saliva Based Screening Market Outlook, by Application, 2020-2033
5.5.16. U.K. Saliva Based Screening Market Outlook, by End User, 2020-2033
5.5.17. Spain Saliva Based Screening Market Outlook, by Product Type, 2020-2033
5.5.18. Spain Saliva Based Screening Market Outlook, by Purpose, 2020-2033
5.5.19. Spain Saliva Based Screening Market Outlook, by Application, 2020-2033
5.5.20. Spain Saliva Based Screening Market Outlook, by End User, 2020-2033
5.5.21. Russia Saliva Based Screening Market Outlook, by Product Type, 2020-2033
5.5.22. Russia Saliva Based Screening Market Outlook, by Purpose, 2020-2033
5.5.23. Russia Saliva Based Screening Market Outlook, by Application, 2020-2033
5.5.24. Russia Saliva Based Screening Market Outlook, by End User, 2020-2033
5.5.25. Rest of Europe Saliva Based Screening Market Outlook, by Product Type, 2020-2033
5.5.26. Rest of Europe Saliva Based Screening Market Outlook, by Purpose, 2020-2033
5.5.27. Rest of Europe Saliva Based Screening Market Outlook, by Application, 2020-2033
5.5.28. Rest of Europe Saliva Based Screening Market Outlook, by End User, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Saliva Based Screening Market Outlook, 2020 - 2033
6.1. Asia Pacific Saliva Based Screening Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
6.1.1. Saliva Collection Devices
6.1.2. Saliva Nucleic Acid Purification Kits
6.1.3. Saliva Base Detection Kits
6.2. Asia Pacific Saliva Based Screening Market Outlook, by Purpose, Value (US$ Mn), 2020-2033
6.2.1. Research
6.2.2. Diagnostics
6.3. Asia Pacific Saliva Based Screening Market Outlook, by Application, Value (US$ Mn), 2020-2033
6.3.1. Infection analysis/detection
6.3.2. Genomic analysis
6.3.3. Proteomics
6.3.4. Pharmacogenomics
6.3.5. Liquid biopsy
6.4. Asia Pacific Saliva Based Screening Market Outlook, by End User, Value (US$ Mn), 2020-2033
6.4.1. Hospitals & Clinics
6.4.2. Diagnostic laboratories
6.4.3. Academic & research institutes
6.4.4. Biopharmaceuticals & CRO’s
6.5. Asia Pacific Saliva Based Screening Market Outlook, by Country, Value (US$ Mn), 2020-2033
6.5.1. China Saliva Based Screening Market Outlook, by Product Type, 2020-2033
6.5.2. China Saliva Based Screening Market Outlook, by Purpose, 2020-2033
6.5.3. China Saliva Based Screening Market Outlook, by Application, 2020-2033
6.5.4. China Saliva Based Screening Market Outlook, by End User, 2020-2033
6.5.5. Japan Saliva Based Screening Market Outlook, by Product Type, 2020-2033
6.5.6. Japan Saliva Based Screening Market Outlook, by Purpose, 2020-2033
6.5.7. Japan Saliva Based Screening Market Outlook, by Application, 2020-2033
6.5.8. Japan Saliva Based Screening Market Outlook, by End User, 2020-2033
6.5.9. South Korea Saliva Based Screening Market Outlook, by Product Type, 2020-2033
6.5.10. South Korea Saliva Based Screening Market Outlook, by Purpose, 2020-2033
6.5.11. South Korea Saliva Based Screening Market Outlook, by Application, 2020-2033
6.5.12. South Korea Saliva Based Screening Market Outlook, by End User, 2020-2033
6.5.13. India Saliva Based Screening Market Outlook, by Product Type, 2020-2033
6.5.14. India Saliva Based Screening Market Outlook, by Purpose, 2020-2033
6.5.15. India Saliva Based Screening Market Outlook, by Application, 2020-2033
6.5.16. India Saliva Based Screening Market Outlook, by End User, 2020-2033
6.5.17. Southeast Asia Saliva Based Screening Market Outlook, by Product Type, 2020-2033
6.5.18. Southeast Asia Saliva Based Screening Market Outlook, by Purpose, 2020-2033
6.5.19. Southeast Asia Saliva Based Screening Market Outlook, by Application, 2020-2033
6.5.20. Southeast Asia Saliva Based Screening Market Outlook, by End User, 2020-2033
6.5.21. Rest of SAO Saliva Based Screening Market Outlook, by Product Type, 2020-2033
6.5.22. Rest of SAO Saliva Based Screening Market Outlook, by Purpose, 2020-2033
6.5.23. Rest of SAO Saliva Based Screening Market Outlook, by Application, 2020-2033
6.5.24. Rest of SAO Saliva Based Screening Market Outlook, by End User, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Saliva Based Screening Market Outlook, 2020 - 2033
7.1. Latin America Saliva Based Screening Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
7.1.1. Saliva Collection Devices
7.1.2. Saliva Nucleic Acid Purification Kits
7.1.3. Saliva Base Detection Kits
7.2. Latin America Saliva Based Screening Market Outlook, by Purpose, Value (US$ Mn), 2020-2033
7.2.1. Research
7.2.2. Diagnostics
7.3. Latin America Saliva Based Screening Market Outlook, by Application, Value (US$ Mn), 2020-2033
7.3.1. Infection analysis/detection
7.3.2. Genomic analysis
7.3.3. Proteomics
7.3.4. Pharmacogenomics
7.3.5. Liquid biopsy
7.4. Latin America Saliva Based Screening Market Outlook, by End User, Value (US$ Mn), 2020-2033
7.4.1. Hospitals & Clinics
7.4.2. Diagnostic laboratories
7.4.3. Academic & research institutes
7.4.4. Biopharmaceuticals & CRO’s
7.5. Latin America Saliva Based Screening Market Outlook, by Country, Value (US$ Mn), 2020-2033
7.5.1. Brazil Saliva Based Screening Market Outlook, by Product Type, 2020-2033
7.5.2. Brazil Saliva Based Screening Market Outlook, by Purpose, 2020-2033
7.5.3. Brazil Saliva Based Screening Market Outlook, by Application, 2020-2033
7.5.4. Brazil Saliva Based Screening Market Outlook, by End User, 2020-2033
7.5.5. Mexico Saliva Based Screening Market Outlook, by Product Type, 2020-2033
7.5.6. Mexico Saliva Based Screening Market Outlook, by Purpose, 2020-2033
7.5.7. Mexico Saliva Based Screening Market Outlook, by Application, 2020-2033
7.5.8. Mexico Saliva Based Screening Market Outlook, by End User, 2020-2033
7.5.9. Argentina Saliva Based Screening Market Outlook, by Product Type, 2020-2033
7.5.10. Argentina Saliva Based Screening Market Outlook, by Purpose, 2020-2033
7.5.11. Argentina Saliva Based Screening Market Outlook, by Application, 2020-2033
7.5.12. Argentina Saliva Based Screening Market Outlook, by End User, 2020-2033
7.5.13. Rest of LATAM Saliva Based Screening Market Outlook, by Product Type, 2020-2033
7.5.14. Rest of LATAM Saliva Based Screening Market Outlook, by Purpose, 2020-2033
7.5.15. Rest of LATAM Saliva Based Screening Market Outlook, by Application, 2020-2033
7.5.16. Rest of LATAM Saliva Based Screening Market Outlook, by End User, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Saliva Based Screening Market Outlook, 2020 - 2033
8.1. Middle East & Africa Saliva Based Screening Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
8.1.1. Saliva Collection Devices
8.1.2. Saliva Nucleic Acid Purification Kits
8.1.3. Saliva Base Detection Kits
8.2. Middle East & Africa Saliva Based Screening Market Outlook, by Purpose, Value (US$ Mn), 2020-2033
8.2.1. Research
8.2.2. Diagnostics
8.3. Middle East & Africa Saliva Based Screening Market Outlook, by Application, Value (US$ Mn), 2020-2033
8.3.1. Infection analysis/detection
8.3.2. Genomic analysis
8.3.3. Proteomics
8.3.4. Pharmacogenomics
8.3.5. Liquid biopsy
8.4. Middle East & Africa Saliva Based Screening Market Outlook, by End User, Value (US$ Mn), 2020-2033
8.4.1. Hospitals & Clinics
8.4.2. Diagnostic laboratories
8.4.3. Academic & research institutes
8.4.4. Biopharmaceuticals & CRO’s
8.5. Middle East & Africa Saliva Based Screening Market Outlook, by Country, Value (US$ Mn), 2020-2033
8.5.1. GCC Saliva Based Screening Market Outlook, by Product Type, 2020-2033
8.5.2. GCC Saliva Based Screening Market Outlook, by Purpose, 2020-2033
8.5.3. GCC Saliva Based Screening Market Outlook, by Application, 2020-2033
8.5.4. GCC Saliva Based Screening Market Outlook, by End User, 2020-2033
8.5.5. South Africa Saliva Based Screening Market Outlook, by Product Type, 2020-2033
8.5.6. South Africa Saliva Based Screening Market Outlook, by Purpose, 2020-2033
8.5.7. South Africa Saliva Based Screening Market Outlook, by Application, 2020-2033
8.5.8. South Africa Saliva Based Screening Market Outlook, by End User, 2020-2033
8.5.9. Egypt Saliva Based Screening Market Outlook, by Product Type, 2020-2033
8.5.10. Egypt Saliva Based Screening Market Outlook, by Purpose, 2020-2033
8.5.11. Egypt Saliva Based Screening Market Outlook, by Application, 2020-2033
8.5.12. Egypt Saliva Based Screening Market Outlook, by End User, 2020-2033
8.5.13. Nigeria Saliva Based Screening Market Outlook, by Product Type, 2020-2033
8.5.14. Nigeria Saliva Based Screening Market Outlook, by Purpose, 2020-2033
8.5.15. Nigeria Saliva Based Screening Market Outlook, by Application, 2020-2033
8.5.16. Nigeria Saliva Based Screening Market Outlook, by End User, 2020-2033
8.5.17. Rest of Middle East Saliva Based Screening Market Outlook, by Product Type, 2020-2033
8.5.18. Rest of Middle East Saliva Based Screening Market Outlook, by Purpose, 2020-2033
8.5.19. Rest of Middle East Saliva Based Screening Market Outlook, by Application, 2020-2033
8.5.20. Rest of Middle East Saliva Based Screening Market Outlook, by End User, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific, Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Abbott Laboratories
9.4.3. OraSure Technologies, Inc.
9.4.4. Quest Diagnostics Incorporated
9.4.5. Laboratory Corporation of America (LabCorp)
9.4.6. Salimetrics, LLC
9.4.7. Neogen Corporation
9.4.8. Hologic, Inc.
9.4.9. F. Hoffmann-La Roche Ltd, QIAGEN N.V.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations